 |
The Benefits and Potential Risks of CT Scans in Children
There are seven million computed tomography (CT) scans performed in children each year in the US, a number that is increasing about 10 percent annually. While CT is a very useful imaging tool that produces quality diagnostic images of underlying conditions, which in some cases can be missed by other imaging techniques, CT scans expose patients to significantly more radiation than standard x-rays. This is an issue of particular importance for children, whose tissues are more sensitive to the larger relative radiation doses they receive. To provide guidance, the Society for Pediatric Radiology, including physicians from Memorial Sloan-Kettering Cancer Center, has launched a project known as Image Gently, which seeks to decrease unnecessary imaging and radiation levels in children. |
 |
Updates & News
Updated Head and Neck Cancer Overview
The head and neck is an anatomically diverse part of the body, made up of soft tissues, bones, and a variety of glands and organs. In this newly revised section, you can find information about our expertise in treating patients with head and neck cancers, our services, and our research.
Second Annual Major Trends in Modern Cancer Research Seminar
More than 500 people filled the Rockefeller Research Laboratories on November 8 to hear three of Memorial Sloan-Kettering's leading researchers highlight current trends in cancer research -- explaining how the latest developments in various areas of science contribute to better treatments for cancer patients. These lectures can be viewed directly on our site in Flash or as a podcast in iTunes.
Research at Memorial Sloan-Kettering
Benefit of Cancer Prevention Surgery Differs Between Women with BRCA1 and BRCA2 Mutations
The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan-Kettering Cancer Center is the first prospective examination of the impact of this procedure in which BRCA2 mutation carriers were analyzed separately from BRCA1 mutation carriers.
Novel Mechanism Found That May Boost Impaired Function of Leukemia Protein
A new study led by researchers at Memorial Sloan-Kettering Cancer Center reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.
PSA Testing Can Predict Advanced Prostate Cancer
A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan-Kettering Cancer Center and Lund University in Sweden.
Staff Spotlight
An Interview with Maureen Killackey
From an early age, Maureen Killackey, Deputy Physician-in-Chief and Medical Director of the Memorial Sloan-Kettering Regional Care Network, has recognized the importance of using one's skills to give back to the community.
Public Events
The Changing Face of Breast Cancer: Where We Are, Where We Are Going, and How
On Thursday, April 3, join Memorial Sloan-Kettering Cancer Center's Deputy Physician-in-Chief for Breast Cancer Programs, Larry Norton, MD, for a comprehensive discussion of breast cancer that will address the following topics: biology, prevention, diagnosis, prognostication, management, and adjustment to life after treatment.
Head and Neck Cancer Screenings
On Thursday, April 17, from 9:00 AM to 12:00 noon, Memorial Sloan-Kettering doctors will offer free head and neck cancer screenings at the Enid Haupt Pavilion, located at 425 E. 67th Street, 4th Floor, Suite 5. No appointment is necessary. For more information, call 646-497-9161.
What You Should Know About Esophageal and Pancreatic Cancers
On Thursday, May 1, join Memorial Sloan-Kettering physicians Karyn Aalami Goodman, MD, an assistant attending radiation oncologist in the Department of Radiation Oncology, and Eileen M. O'Reilly, MB, BCh, BAO, an associate attending physician on the Gastrointestinal Oncology Service, for a conversation about esophageal and pancreatic cancers.
An Update on Complementary Therapies, Herbs, and Other Botanicals in Cancer Care
On Tuesday, May 20, join Memorial Sloan-Kettering physicians Barrie R. Cassileth, PhD, Chief; Gary E. Deng, MD, PhD, Associate Attending Physician; and Kathleen M. Wesa, MD, Assistant Attending Physician -- all of MSKCC's Integrative Medicine Service -- for a discussion of complementary therapies.
Last Updated: Mar. 3, 2008
|
